To include your compound in the COVID-19 Resource Center, submit it here.

Nanosens debuts latest CRISPR diagnostic on a graphene chip

Nanosens unveiled a device on Monday that can detect genomic mutations in minutes using graphene-based electrical signals instead of chemical labels, making it at least the third company to harness CRISPR as a diagnostic tool in the past year. The company plans to

Read the full 437 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE